Oji Paper

Oji Holdings, historically known as Oji Paper, is a Japanese conglomerate that has successfully diversified from its traditional paper manufacturing roots into advanced life sciences and functional materials. The company leverages its deep expertise in wood-derived cellulose to develop Sulfated Cellulose Nanofiber (S-CNF), a novel therapeutic modality with potent anti-inflammatory and antiviral properties. Their clinical pipeline includes candidates for knee osteoarthritis and dry eye, alongside research into antiviral coatings and medical-grade materials. Oji's transition into the biotech space is spearheaded by its Innovation Promotion Division, which focuses on sustainable, bio-based solutions for the healthcare industry. The company also produces hygiene products and cell culture substrates, positioning itself as a key player in the global bio-economy.